Funding available for transformational novel insulins research

November 28, 2023

We are excited to announce the first funding call under the Novel Insulins part of the Type 1 Diabetes Grand Challenge. The funding call, titled Novel Insulins Innovation Incubator, aims to support transformative research to drive transformational therapy development.

Novel Insulins Innovation Incubator

The funding call is open to international academic researchers and small to medium sized companies from the fields of diabetes, chemistry, biotechnology, pharmacology and more to apply. We are encouraging applicants to design high risk/high reward projects that have the potential to transform insulin therapy. We welcome any project investigating a bold concept for novel insulins, including glucose-responsive insulins and insulins targeting the liver.

Funding available

We are offering initial awards of up to £500,000 for one year for the first phase of the Novel Insulins Innovation Incubator. If the projects give rise to promising results, which could benefit people with type 1, the researchers may be invited to apply for further funding of around £3 million to develop their project.

Involving people with type 1

All research projects must consider the views and needs of people living with type 1 diabetes. Equality, diversity, and inclusion (EDI) must also be taken into account within the application. We also encourage meaningful involvement of people affected by type 1 in the project as their insight improves the quality and relevance of research.

Rachel Connor, Director of Research Partnerships at JDRF UK, said:

“The Type 1 Diabetes Grand Challenge Novel Insulins Innovation Incubator funding call is an exciting opportunity for scientists all around the world to apply for funding to support creative work that could deliver transformative approaches to insulin therapy for people with type 1 diabetes. The Incubator is a new approach for the Grand Challenge and is designed to move swiftly to identify the projects with the most promise, so that research that can improve life with type 1 can get underway as rapidly as possible.”

Apply for funding

Please see further details about the funding call and how to apply.

If you are interested in applying, please submit your letter of intent by 30 January 2024.

The very best applicants will then be invited to pitch their ideas in a 15-minute presentation to our reviewing panel on 20 February 2024.

You may also be interested in

Apply for funding
Apply for funding

The Type 1 Diabetes Grand Challenge research grants provide funding for exceptional scientists and projects with the greatest potential to change the lives of people with type 1 diabetes.

Virtual symposium on novel insulins
Virtual symposium on novel insulins

Earlier this year, the Type 1 Diabetes Grand Challenge brought leading experts and researchers from around the world together to share their progress, challenges and hopes for developing new forms of insulin.

Five promising research ideas for novel insulins
Five promising research ideas for novel insulins

Get inspired and discover the most exciting ideas that were discussed at our novel insulins virtual symposium.